Sign In
Free Newsletter
MD-based Novavax raises 2026 outlook on strength in vaccine deals
Gaithersburg-based Novavax raised its adjusted revenue forecast for 2026, as it expects milestone payments from vaccine supply and licensing deals to offset sagging demand.
MD-based Novavax signs agreement with Pfizer for vaccine development
Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to vaccines.
MD-based Novavax raises annual revenue forecast on strength of vaccine deals
Gaithersburg-based Novavax raised its annual revenue forecast, banking on milestone payments from vaccine supply and licensing deals.
FDA approves updated COVID-19 shots but limits access for some kids and adults
FDA narrows COVID-19 vaccine access, revokes Pfizer for under-5, and limits shots to high-risk adults and children.
New Trump vaccine policy limits access to COVID shots
Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under the Trump administration.
FDA approves Novavax COVID-19 shot but with unusual restrictions
The FDA has issued a long-awaited approval of Maryland-based Novavax’s COVID-19 vaccine but with unusual restrictions.
COVID booster dose from Gaithersburg-based Novavax approved
U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Gaithersburg-based Novavax.
COVID-19 vaccine from Maryland-based Novavax approved by regulators
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.
FDA advisers back Novavax COVID-19 shots as new US option
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the FDA backed a more traditional type of shot.
Novavax gets $4M for COVID-19 vaccine, teams with Emergent
A Gaithersburg drug company has received $4 million in funding from a nongovernmental organization to develop a COVID-19 vaccine and is teaming with another Gaithersburg drug company for development and manufacturing.
Novavax gets FDA fast track designation for flu vaccine
A Gaithersburg biotechnology company has received a designation from the Food and Drug Administration aimed at quickening the development of one of its drugs.
Novavax begins phase 3 trial of flu vaccine candidate
A Gaithersburg biotechnology company is beginning a clinical trial which the FDA can examine when determining whether to approve its influenza vaccine.
